When “Doing Something” Isn’t Enough: Tracking Opioid Settlement Spending

When “Doing Something” Isn’t Enough: Tracking Opioid Settlement Spending

Curious about how funds from the opioid settlement are being spent? Aneri Pattani, a senior correspondent for KFF Health News, joins Jeff Kwame to dive into this complex issue. Pattani has been tracking the opioid settlement dollars for over three years, aiming to understand whether the funds are making a real difference in tackling addiction. You'll hear about some eyebrow-raising expenditures, like concerts and track renovations, that might not directly address opioid addiction.

But don't worry, most of the funds are going towards effective solutions like naloxone distribution and housing services. The episode also touches on the role of various pharmaceutical companies and retail pharmacies in the opioid crisis, highlighting that it's not just Purdue Pharma. As Pattani explains, the guidelines for spending are quite flexible, leading to a mix of effective and questionable uses.

The conversation delves into whether stricter federal oversight could help ensure these funds are used appropriately, while acknowledging the good intentions behind many spending decisions. With anecdotes from local communities and insights into how public opinion can influence spending, this episode is both eye-opening and informative. If you're interested in how public health policies are shaped or want to know more about how your community is using settlement funds, this is a must-listen.

Get ready to question how these dollars are impacting the fight against addiction and consider what changes could make them more effective.